Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Hoth · SciRah

Researcher profile · Semantic Scholar

D. Hoth

Share profile

D. Hoth — researcher profile on SciRah

h-index: 15
Works: 55
Citations: 1,474

Most-cited papers

5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer.
John S. Macdonald, P. Schein, P. Woolley, T. Smythe +7 more
1980Annals of Internal Medicine328 citations
Semantic Scholar
Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo.
S. Broder, Jerry E. Collins, P. Markham, R. Redfield +11 more
1985The Lancet194 citations
Semantic Scholar
A comparison of mitoxantrone and doxorubicin in breast cancer.
James A. Neidhart, Diane Gochnour, R. Roach, D. Hoth +1 more
1986Journal of Clinical Oncology112 citations
Semantic Scholar
Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion
J. Gullo, C. Litterst, P. J. Maguire, B. Sikic +2 more
2004Cancer Chemotherapy and Pharmacology105 citations
Semantic Scholar
Gallium nitrate: the second metal with clinical activity.
B. Foster, K. Clagett-Carr, D. Hoth, B. Leyland-Jones
1986Cancer treatment reports101 citations
Semantic Scholar
2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drug.
P. O'Dwyer, B. Wagner, B. Leyland-Jones, R. Wittes +2 more
1988Annals of Internal Medicine99 citations
Semantic Scholar
Clinical drug development: an analysis of phase II trials, 1970-1985.
S. Marsoni, D. Hoth, R. Simon, B. Leyland-Jones +2 more
1987Cancer treatment reports86 citations
Semantic Scholar
Surrogate Markers in AIDS: Where Are We? Where Are We Going?
S. Lagakos, D. Hoth
1992Annals of Internal Medicine75 citations
Semantic Scholar
Central nervous system toxicity of fludarabine phosphate.
H.-G. Chun, B. Leyland-Jones, S. M. Caryk, D. Hoth
1986Cancer treatment reports67 citations
Semantic Scholar
HIV Vaccine Development: A Progress Report
D. Hoth, D. Bolognesi, L. Corey, S. Vermund
1994Annals of Internal Medicine41 citations Open access
Semantic Scholar
Homoharringtonine--perspectives on an active new natural product.
P. O'Dwyer, Susan A. King, D. Hoth, M. Suffness +1 more
1986Journal of Clinical Oncology33 citations
Semantic Scholar
Phase I studies on chlorozotocin
D. Hoth, P. Woolley, D. Green, J. Macdonald +1 more
1978Clinical pharmacology and therapy29 citations
Semantic Scholar
Hexamethylene bisacetamide: a polar-planar compound entering clinical trials as a differentiating agent.
H.-G. Chun, B. Leyland-Jones, D. Hoth, D. Shoemaker +6 more
1986Cancer treatment reports28 citations
Semantic Scholar
Arabinosyl-5-azacytosine: A novel nucleoside entering clinical trials
J. Grem, D. Shoemaker, D. Hoth, S. A. King +6 more
1987Investigational new drugs18 citations
Semantic Scholar
Trimetrexate: clinical development of a nonclassical antifolate.
P. O'Dwyer, R. Delap, S. A. King, A. Grillo-López +2 more
1987NCI monographs : a publication of the National Cancer Institute15 citations
Semantic Scholar
Site visit monitoring program of the clinical cooperative groups: results of the first 3 years.
J. Mauer, D. Hoth, D. Macfarlane, L. Hammershaimb +1 more
1985Cancer treatment reports15 citations
Semantic Scholar
Preparing for HIV vaccine efficacy trials: Partnerships and challenges
S. Vermund, R. Fischer, R. Hoff, W. Rida +4 more
199314 citations
Semantic Scholar
Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.
P. O'Dwyer, B. Cheson, B. Leyland-Jones, S. A. King +1 more
1988Oncology12 citations
Semantic Scholar
Flavone acetic acid (LM 975, NSC 347512) A novel antitumor agent
P. O'Dwyer, D. Shoemaker, D. Zaharko, C. Grieshaber +7 more
2004Cancer Chemotherapy and Pharmacology9 citations
Semantic Scholar
How can epidemiology assist in guiding interventions for the acquired immunodeficiency syndrome/human immunodeficiency virus?
Sten H. Vermund, D. Hoth
1990Annals of Epidemiology8 citations
Semantic Scholar
Natural history and staging of colon cancer.
D. Hoth, P. Petrucci
1976Seminars in Oncology8 citations
Semantic Scholar
Pyrazole: preclinical reassessment
P. O'Dwyer, S. A. King, J. Plowman, C. Grieshaber +2 more
1988Investigational new drugs7 citations
Semantic Scholar
Mitomycin C: Experience in the United States, with emphasis on gastric cancer
P. Schein, J. Macdonald, D. Hoth, P. Wooley
2004Cancer Chemotherapy and Pharmacology6 citations
Semantic Scholar
Clinical development of biological response modifiers: comparison with cytotoxic drugs.
M. Hawkins, D. Hoth, R. Wittes
1986Seminars in Oncology6 citations
Semantic Scholar
Pentamethylmelamine: review of an aqueous analog of hexamethylmelamine.
B. Foster, K. Clagett-Carr, D. Hoth, B. Leyland-Jones
1986Cancer treatment reports6 citations
Semantic Scholar
Indicine N-oxide: clinical use of a pyrrolizidine alkaloid.
Susan A. King, M. Suffness, B. Leyland-Jones, D. Hoth +1 more
1987Cancer treatment reports5 citations
Semantic Scholar
Anaphylactic reactions to diaziquone.
J. G. Posada, P. O'Dwyer, D. Hoth
1984Cancer treatment reports5 citations
Semantic Scholar
Chapter 33 – CHLOROZOTOCIN: CLINICAL TRIALS
D. Hoth, Luz Duque‐Hammershaimb
19815 citations
Semantic Scholar
Phase II study of chlorozotocin in non-small cell carcinoma of the lung.
C. J. Cornell, D. Hoth, T. Pajak
1981Cancer treatment reports5 citations
Semantic Scholar
Hypersensitivity reactions to deoxycoformycin
P. O'Dwyer, S. A. King, E. Eisenhauer, J. Grem +1 more
2004Cancer Chemotherapy and Pharmacology4 citations
Semantic Scholar
NIH conference. HIV vaccine development: a progress report.
D. Hoth, D. Bolognesi, L. Corey, S. Vermund
1994Annals of Internal Medicine4 citations
Semantic Scholar
Patient treatment on a compassionate basis: documentation of high adverse drug reaction rate.
B. Leyland-Jones, B. Davies, Kathleen Clagett-Carr, D. Shoemaker +8 more
1992Annals of Oncology4 citations Open access
Semantic Scholar
AIDS drug discovery and development.
J. Mcgowan, D. Hoth
1989Journal of Acquired Immune Deficiency Syndromes4 citations
Semantic Scholar
Dichloromethotrexate--a critical reassessment.
P. O'Dwyer, B. Leyland-Jones, M. T. Alonso, M. Eisenberger +1 more
1985Journal of Clinical Oncology4 citations
Semantic Scholar
Human immunodeficiency virus infection
T. Eickhoff, D. Gullen, W. Addington, L. Aledort +41 more
19942 citations
Semantic Scholar
New drug development in head and neck oncology
M. Eisenberger, D. Hoth, J. Posada
19842 citations
Semantic Scholar
2′-Deoxycoformycin (Pentostatin) for Lymphoid Malignancies
P. O'Dwyer, B. Wagner, B. Leyland-Jones, R. Wittes +2 more
20201 citations
Semantic Scholar
Oncology and public health
Jia-Hong Zong, L. Eckert, L. Zhang, W.-S. Dai +308 more
20121 citations Open access
Semantic Scholar
Progress and Trends for Cancer Drug Approval – an Analysis of FDA Advisory Committee
J. Chan, I. Amanam, T. Kiet, N. Young-Lin +3 more
20121 citations Open access
Semantic Scholar
Discussion: Susan Ellenberg, M W Myers and D F Hoth, the use of external monitoring committees in trials of infectious diseases
S. Ellenberg, M. Myers, D. Hoth, G. Tognoni +2 more
19931 citations
Semantic Scholar
Hypersensitivity reactions to amsacrine.
D. Perry, R. Weiss, D. Hoth
1985Cancer treatment reports1 citations
Semantic Scholar
A phase II study of chlorozotocin in advanced large bowel carcinoma: A cooperative study between two institutions
A. Schutt, D. Hoth, C. Moertel, P. Schein +2 more
1984American Journal of Clinical Oncology1 citations
Semantic Scholar
Traitement du cancer
Thomas F. White, D. Hoth
20140 citations
Semantic Scholar
FDA approval of oncology drugs in association of relative survival benefits - An analysis of the oncology drug applications over the 10 years
N. Young-Lin, I. Amanam, T. Kiet, K. Blansit +4 more
20130 citations
Semantic Scholar
Applications for oncologic drugs — Lessons from the oncologic drug advisory committee
I. Amanam, T. Kiet, N. Young-Lin, L.-M. Chen +6 more
20120 citations
Semantic Scholar
Predictive model for cancer drug approval – An analysis of FDA drug submissions over the last decade
I. Amanam, T. Kiet, N. Young-Lin, L.-M. Chen +6 more
20120 citations
Semantic Scholar
Trends and progress of oncology drug development — An analysis of the FDA oncologic drug advisory committee reviews
I. Amanam, T. Kiet, N. Young-Lin, L.-M. Chen +6 more
20120 citations
Semantic Scholar
Adriamycin and Mitomycin-C ( FAM 11 ) in Advanced Gastric A denocarcinoma
P. Woolley, John, S. Macdonald, Tarilyn +5 more
20060 citations
Semantic Scholar
The Potential of Vaccines for the Control of AIDS
M. Johnston, P. Fast, M. C. Walker, D. Hoth
19940 citations Open access
Semantic Scholar
Methodological issues in AIDS clinical trials. Introduction.
D. Hoth
1990Journal of Acquired Immune Deficiency Syndromes0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Leyland-Jones×10
Invite
B. Leyland-Jones — researcher profile on SciRah
P. O'Dwyer×9
Invite
P. O'Dwyer — researcher profile on SciRah
B. Leyland-Jones×6
Invite
B. Leyland-Jones — researcher profile on SciRah
S. A. King×6
Invite
S. A. King — researcher profile on SciRah

×6

Invite

I. Amanam — researcher profile on SciRah

Invite

T. Kiet — researcher profile on SciRah

N. Young-Lin×6

Invite

N. Young-Lin — researcher profile on SciRah

Invite

D. Kapp — researcher profile on SciRah

Invite

B. Monk — researcher profile on SciRah

Invite

R. Wittes — researcher profile on SciRah

Invite

J. Chan — researcher profile on SciRah

Invite

P. Schein — researcher profile on SciRah